好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Functional brain connectome organization associated with atrophy and hypometabolism in posterior cortical atrophy
Aging, Dementia, and Behavioral Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
9-029

To investigate functional brain network architecture in patients with posterior cortical atrophy (PCA), within atrophic and hypometabolic regions, and according with CSF AD profile.

 

  Multimodal imaging approaches have been gaining momentum in neuroscience due to the increasing availability of different imaging datasets and, most importantly, to the need of new tools to define more reliable biomarkers. In the present study, for the first time, we will combine non-redundant brain imaging and biologic data in patients affected by a PCA (n=18).

The human macroscale connectome was constructed from resting-state functional MRI. Graph analysis and connectomics assessed topological network properties, regional functional connectivity, and intra- and inter-hemispheric between-lobe connectivity, also within hypometabolic and atrophic nodes, and according to the CSF AD profile. Atrophic and hypometabolic regions were identified by voxel based morphometry on 3D T1-weighted MRI and FDG-PET analyses, respectively. PCA were classified with typical CSF AD (PCA-tAD; abnormal amyloid, T-tau, P-tau), atypical AD CSF (PCA-aAD; abnormal amyloid only), or non-AD CSF (PCA-nonAD) profile. Fifty-nine age- and sex- matched controls were enrolled.

 


  All PCA patients showed diffuse functional connectome alterations at both global and lobar level, except in the frontal region. We observed functional connectivity breakdown between the posterior brain nodes, a widespread loss of both intra- and inter-hemispheric functional connections, as well as between hypometabolic, hypometabolic and atrophic and spared nodes. No alterations were observed in the connections among more anterior, spared areas. PCA-tAD patients showed more diffuse alterations.

Present multimodal neuroimaging approach showed the distant functional effects of the atrophy and hypometabolism occurring in the posterior brain regions on preserved anterior brain areas. PCA patients with both abnormal CSF amyloid and T-Tau/P-tau show more severe connectome alterations, maybe suggesting a more aggressive progression.

Authors/Disclosures
Raffaella Migliaccio (Hopital de la Pitie-Salpetriere)
PRESENTER
Raffaella Migliaccio has nothing to disclose.
Federica Agosta (San Raffaele Scientific Institute) Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Silvia Basaia Silvia Basaia has nothing to disclose.
Camilla Cividini, MSc (San Raffaele Scientific Institute, Vita-Salute San Raffaele University) Ms. Cividini has nothing to disclose.
Maxime Montembeault, PhD (UCSF Memory and Aging Center) Dr. Montembeault has nothing to disclose.
No disclosure on file
No disclosure on file
Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.